![](/img/cover-not-exists.png)
PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement
K. Heidorn, W. Mittelmeier, G. Kundt, R. SkripitzVolume:
15
Year:
2012
Language:
english
DOI:
10.1016/j.jval.2012.08.1383
File:
PDF, 59 KB
english, 2012